ARWR logo

ARWR Cash from operations

annual CFO:

-$462.85M-$308.96M(-200.77%)
September 30, 2024

Summary

  • As of today (May 24, 2025), ARWR annual cash flow from operations is -$462.85 million, with the most recent change of -$308.96 million (-200.77%) on September 30, 2024.
  • During the last 3 years, ARWR annual CFO has fallen by -$634.16 million (-370.18%).
  • ARWR annual CFO is now -367.49% below its all-time high of $173.03 million, reached on September 30, 2019.

Performance

ARWR Cash from operations Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRcash flow metrics

quarterly CFO:

$460.05M+$606.33M(+414.52%)
March 31, 2025

Summary

  • As of today (May 24, 2025), ARWR quarterly cash flow from operations is $460.05 million, with the most recent change of +$606.33 million (+414.52%) on March 31, 2025.
  • Over the past year, ARWR quarterly CFO has increased by +$552.43 million (+598.02%).
  • ARWR quarterly CFO is now at all-time high.

Performance

ARWR quarterly CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRcash flow metrics

TTM CFO:

$61.15M+$552.43M(+112.45%)
March 31, 2025

Summary

  • As of today (May 24, 2025), ARWR TTM cash flow from operations is $61.15 million, with the most recent change of +$552.43 million (+112.45%) on March 31, 2025.
  • Over the past year, ARWR TTM CFO has increased by +$318.07 million (+123.80%).
  • ARWR TTM CFO is now -66.78% below its all-time high of $184.08 million, reached on June 30, 2021.

Performance

ARWR TTM CFO Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherARWRcash flow metrics

Cash from operations Formula

CFO = Net Income + Non Cash Expenses + Changes In Working Capital

ARWR Cash from operations Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-200.8%+598.0%+123.8%
3 y3 years-370.2%+633.4%+217.1%
5 y5 years-367.5%+1767.8%+328.4%

ARWR Cash from operations Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-370.2%at lowat high+414.5%at high+112.5%
5 y5-year-367.5%at lowat high+414.5%-66.8%+112.5%
alltimeall time-367.5%at lowat high+414.5%-66.8%+112.5%

ARWR Cash from operations History

DateAnnualQuarterlyTTM
Mar 2025
-
$460.05M(-414.5%)
$61.15M(-112.4%)
Dec 2024
-
-$146.27M(+6.6%)
-$491.28M(+6.1%)
Sep 2024
-$462.85M(+200.8%)
-$137.22M(+18.9%)
-$462.85M(+31.7%)
Jun 2024
-
-$115.42M(+24.9%)
-$351.56M(+36.8%)
Mar 2024
-
-$92.38M(-21.6%)
-$256.92M(+30.9%)
Dec 2023
-
-$117.84M(+354.5%)
-$196.21M(+27.5%)
Sep 2023
-$153.89M(+13.0%)
-$25.93M(+24.8%)
-$153.89M(-21.8%)
Jun 2023
-
-$20.78M(-34.4%)
-$196.70M(-19.6%)
Mar 2023
-
-$31.67M(-58.1%)
-$244.74M(+62.8%)
Dec 2022
-
-$75.52M(+9.9%)
-$150.34M(+10.4%)
Sep 2022
-$136.13M(-179.5%)
-$68.74M(-0.1%)
-$136.13M(+48.9%)
Jun 2022
-
-$68.81M(-209.7%)
-$91.42M(+75.1%)
Mar 2022
-
$62.73M(-202.3%)
-$52.22M(-135.1%)
Dec 2021
-
-$61.31M(+155.1%)
$148.93M(-13.1%)
Sep 2021
$171.31M(-278.8%)
-$24.03M(-18.8%)
$171.31M(-6.9%)
Jun 2021
-
-$29.61M(-111.2%)
$184.08M(+2.1%)
Mar 2021
-
$263.87M(-778.0%)
$180.26M(-262.1%)
Dec 2020
-
-$38.92M(+245.7%)
-$111.19M(+16.1%)
Sep 2020
-$95.80M(-155.4%)
-$11.26M(-66.3%)
-$95.80M(+35.4%)
Jun 2020
-
-$33.43M(+21.2%)
-$70.73M(+164.1%)
Mar 2020
-
-$27.59M(+17.2%)
-$26.78M(+42.6%)
Dec 2019
-
-$23.53M(-270.4%)
-$18.78M(-110.9%)
Sep 2019
$173.03M(-466.4%)
$13.81M(+31.2%)
$173.04M(+10.5%)
Jun 2019
-
$10.53M(-153.7%)
$156.54M(+18.9%)
Mar 2019
-
-$19.59M(-111.6%)
$131.61M(-3.1%)
Dec 2018
-
$168.28M(-6378.6%)
$135.75M(-387.5%)
Sep 2018
-$47.22M(+97.3%)
-$2.68M(-81.4%)
-$47.22M(-12.1%)
Jun 2018
-
-$14.41M(-6.7%)
-$53.75M(+8.0%)
Mar 2018
-
-$15.44M(+5.1%)
-$49.75M(+2.3%)
Dec 2017
-
-$14.69M(+59.6%)
-$48.63M(+103.1%)
Sep 2017
-$23.94M(-62.8%)
-$9.20M(-11.6%)
-$23.94M(-3.9%)
Jun 2017
-
-$10.41M(-27.3%)
-$24.92M(-24.2%)
Mar 2017
-
-$14.33M(-243.3%)
-$32.86M(-1.3%)
Dec 2016
-
$10.00M(-198.2%)
-$33.28M(-48.3%)
Sep 2016
-$64.43M(-1.9%)
-$10.18M(-44.5%)
-$64.43M(-2.8%)
Jun 2016
-
-$18.35M(+24.4%)
-$66.27M(+8.6%)
Mar 2016
-
-$14.75M(-30.3%)
-$61.03M(-2.6%)
Dec 2015
-
-$21.15M(+75.9%)
-$62.66M(-4.6%)
Sep 2015
-$65.71M(+85.5%)
-$12.02M(-8.4%)
-$65.71M(+1.7%)
Jun 2015
-
-$13.12M(-19.9%)
-$64.61M(+5.5%)
Mar 2015
-
-$16.37M(-32.4%)
-$61.27M(+16.5%)
Dec 2014
-
-$24.20M(+121.6%)
-$52.59M(+48.5%)
Sep 2014
-$35.42M(+86.1%)
-$10.92M(+11.7%)
-$35.42M(+18.5%)
Jun 2014
-
-$9.78M(+27.0%)
-$29.89M(+17.5%)
Mar 2014
-
-$7.70M(+9.6%)
-$25.45M(+14.5%)
Dec 2013
-
-$7.02M(+30.2%)
-$22.22M(+16.7%)
Sep 2013
-$19.03M(+24.1%)
-$5.39M(+1.1%)
-$19.03M(+4.4%)
Jun 2013
-
-$5.33M(+19.4%)
-$18.23M(+8.6%)
Mar 2013
-
-$4.47M(+16.4%)
-$16.78M(+1.9%)
Dec 2012
-
-$3.84M(-16.4%)
-$16.47M(+7.4%)
Sep 2012
-$15.34M
-$4.59M(+18.0%)
-$15.34M(+23.6%)
Jun 2012
-
-$3.89M(-6.5%)
-$12.42M(+30.0%)
DateAnnualQuarterlyTTM
Mar 2012
-
-$4.16M(+53.7%)
-$9.55M(+43.1%)
Dec 2011
-
-$2.71M(+62.7%)
-$6.67M(+23.8%)
Sep 2011
-$5.39M(-30.0%)
-$1.66M(+62.4%)
-$5.39M(-13.6%)
Jun 2011
-
-$1.02M(-20.0%)
-$6.24M(-10.8%)
Mar 2011
-
-$1.28M(-10.1%)
-$6.99M(-6.6%)
Dec 2010
-
-$1.42M(-43.3%)
-$7.49M(-2.7%)
Sep 2010
-$7.70M(-49.6%)
-$2.51M(+41.3%)
-$7.70M(+1.3%)
Jun 2010
-
-$1.78M(+0.2%)
-$7.60M(+4.0%)
Mar 2010
-
-$1.77M(+8.6%)
-$7.31M(-28.4%)
Dec 2009
-
-$1.63M(-32.4%)
-$10.21M(-33.2%)
Sep 2009
-$15.28M(-44.6%)
-$2.42M(+62.8%)
-$15.28M(-28.1%)
Jun 2009
-
-$1.48M(-68.3%)
-$21.25M(-22.5%)
Mar 2009
-
-$4.68M(-30.1%)
-$27.42M(-3.6%)
Dec 2008
-
-$6.70M(-20.1%)
-$28.45M(+3.1%)
Sep 2008
-$27.58M(+15.6%)
-$8.38M(+9.5%)
-$27.58M(+7.3%)
Jun 2008
-
-$7.65M(+34.0%)
-$25.70M(+8.5%)
Mar 2008
-
-$5.71M(-2.0%)
-$23.68M(-3.8%)
Dec 2007
-
-$5.83M(-10.2%)
-$24.61M(+3.1%)
Sep 2007
-$23.87M(+61.4%)
-$6.50M(+15.3%)
-$23.87M(+13.5%)
Jun 2007
-
-$5.64M(-15.1%)
-$21.03M(+5.7%)
Mar 2007
-
-$6.64M(+30.5%)
-$19.90M(+19.2%)
Dec 2006
-
-$5.09M(+38.9%)
-$16.69M(+12.9%)
Sep 2006
-$14.79M(+62.6%)
-$3.66M(-18.7%)
-$14.79M(+7.9%)
Jun 2006
-
-$4.51M(+31.3%)
-$13.71M(+13.0%)
Mar 2006
-
-$3.43M(+7.6%)
-$12.14M(+17.4%)
Dec 2005
-
-$3.19M(+23.3%)
-$10.34M(+13.7%)
Sep 2005
-$9.10M(+293.2%)
-$2.59M(-11.9%)
-$9.10M(+26.1%)
Jun 2005
-
-$2.93M(+79.6%)
-$7.21M(+41.6%)
Mar 2005
-
-$1.63M(-16.1%)
-$5.09M(+29.3%)
Dec 2004
-
-$1.95M(+178.0%)
-$3.94M(+70.2%)
Sep 2004
-$2.31M(+1368.5%)
-$700.00K(-14.2%)
-$2.31M(+35.3%)
Jun 2004
-
-$815.40K(+70.3%)
-$1.71M(+89.5%)
Mar 2004
-
-$478.80K(+49.5%)
-$902.80K(+95.5%)
Dec 2003
-
-$320.20K(+232.5%)
-$461.90K(+193.1%)
Sep 2003
-$157.60K(+49.0%)
-$96.30K(+1184.0%)
-$157.60K(+109.0%)
Jun 2003
-
-$7500.00(-80.2%)
-$75.40K(-35.5%)
Mar 2003
-
-$37.90K(+138.4%)
-$116.90K(+23.2%)
Dec 2002
-
-$15.90K(+12.8%)
-$94.90K(-10.4%)
Sep 2002
-$105.80K(+29.3%)
-$14.10K(-71.2%)
-$105.90K(-0.6%)
Jun 2002
-
-$49.00K(+208.2%)
-$106.50K(+46.1%)
Mar 2002
-
-$15.90K(-40.9%)
-$72.90K(-18.9%)
Dec 2001
-
-$26.90K(+83.0%)
-$89.90K(+9.8%)
Sep 2001
-$81.80K(+2.1%)
-$14.70K(-4.5%)
-$81.90K(-7.2%)
Jun 2001
-
-$15.40K(-53.2%)
-$88.30K(-34.3%)
Mar 2001
-
-$32.90K(+74.1%)
-$134.30K(+33.9%)
Dec 2000
-
-$18.90K(-10.4%)
-$100.30K(+25.1%)
Sep 2000
-$80.10K(+127.6%)
-$21.10K(-65.6%)
-$80.20K(+35.7%)
Jun 2000
-
-$61.40K(-5681.8%)
-$59.10K(-2669.6%)
Mar 2000
-
$1100.00(-8.3%)
$2300.00(+91.7%)
Dec 1999
-
$1200.00
$1200.00
Sep 1999
-$35.20K(<-9900.0%)
-
-
Sep 1998
$100.00(-97.8%)
-
-
Sep 1997
$4600.00
-
-

FAQ

  • What is Arrowhead Pharmaceuticals annual cash flow from operations?
  • What is the all time high annual CFO for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals annual CFO year-on-year change?
  • What is Arrowhead Pharmaceuticals quarterly cash flow from operations?
  • What is the all time high quarterly CFO for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals quarterly CFO year-on-year change?
  • What is Arrowhead Pharmaceuticals TTM cash flow from operations?
  • What is the all time high TTM CFO for Arrowhead Pharmaceuticals?
  • What is Arrowhead Pharmaceuticals TTM CFO year-on-year change?

What is Arrowhead Pharmaceuticals annual cash flow from operations?

The current annual CFO of ARWR is -$462.85M

What is the all time high annual CFO for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high annual cash flow from operations is $173.03M

What is Arrowhead Pharmaceuticals annual CFO year-on-year change?

Over the past year, ARWR annual cash flow from operations has changed by -$308.96M (-200.77%)

What is Arrowhead Pharmaceuticals quarterly cash flow from operations?

The current quarterly CFO of ARWR is $460.05M

What is the all time high quarterly CFO for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high quarterly cash flow from operations is $460.05M

What is Arrowhead Pharmaceuticals quarterly CFO year-on-year change?

Over the past year, ARWR quarterly cash flow from operations has changed by +$552.43M (+598.02%)

What is Arrowhead Pharmaceuticals TTM cash flow from operations?

The current TTM CFO of ARWR is $61.15M

What is the all time high TTM CFO for Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals all-time high TTM cash flow from operations is $184.08M

What is Arrowhead Pharmaceuticals TTM CFO year-on-year change?

Over the past year, ARWR TTM cash flow from operations has changed by +$318.07M (+123.80%)
On this page